Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Pharmacol Res. 2022 Mar 5;178:106162. doi: 10.1016/j.phrs.2022.106162

Table 2.

ATR, CHK1, and WEE1 inhibitors in current clinical trials.

ATR inhibitors CHK1 inhibitors WEE1 inhibitors

  • BAY1895344

  • Berzosertib (M6620)

  • Ceralasertib (AZD6738)

  • M4344 (VX-803)

  • Prexasertib (LY2606368)

  • SRA737

  • Adavosertib (AZD1775)